Literature DB >> 28299630

The Role of Interventional Radiology Techniques in the Management of Renal Angiomyolipomas.

Ryan M Kiefer1, S William Stavropoulos2.   

Abstract

PURPOSE OF REVIEW: Although benign, renal angiomyolipoma (AML) may lead to serious complications without appropriate management. The purpose of this review is to describe the role of and evidence for interventional radiology techniques in the management of patients with AML. RECENT
FINDINGS: For patients with renal masses and non-diagnostic imaging studies, image-guided percutaneous biopsy is found to be highly accurate and useful in directing patient management. Once the diagnosis of AML has been made based on either imaging or biopsy, arterial embolization of tumors that are symptomatic or >4 cm has been demonstrated to reduce the risk of hemorrhage as well as tumor size. Percutaneous ablation devices have been proposed as alternative strategies but remain investigational. The utility of interventional radiology techniques including percutaneous core needle biopsy and prophylactic super-selective arterial embolization is safe and effective management strategies for patients presenting with AML tumors.

Entities:  

Keywords:  Angiomyolipoma; Arterial embolization; Interventional radiology; Microwave ablation; Radiofrequency ablation

Mesh:

Year:  2017        PMID: 28299630     DOI: 10.1007/s11934-017-0687-6

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  70 in total

1.  An unusually large renal angiomyolipoma peeping into the right atrium.

Authors:  Thotton Veedu Prasad; Anuradha Singh; Chandan J Das; Amlesh Seth
Journal:  BMJ Case Rep       Date:  2016-06-27

Review 2.  Percutaneous ablation in the kidney.

Authors:  Aradhana M Venkatesan; Bradford J Wood; Debra A Gervais
Journal:  Radiology       Date:  2011-11       Impact factor: 11.105

3.  Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms.

Authors:  Raouf M Seyam; Nabil K Bissada; Said A Kattan; Alaa A Mokhtar; Muhammad Aslam; Wahib E Fahmy; Walid A Mourad; Ali A Binmahfouz; Hassan M Alzahrani; Kamal A Hanash
Journal:  Urology       Date:  2008-09-21       Impact factor: 2.649

4.  Rates of interventional procedures in patients with tuberous sclerosis complex-related renal angiomyolipoma.

Authors:  John Bissler; Katherine Cappell; Hearns Charles; Xue Song; Zhimei Liu; Judith Prestifilippo; John Hulbert
Journal:  Curr Med Res Opin       Date:  2015-06-30       Impact factor: 2.580

5.  Unenhanced CT for the diagnosis of minimal-fat renal angiomyolipoma.

Authors:  Nicola Schieda; Taryn Hodgdon; Mohammed El-Khodary; Trevor A Flood; Matthew D F McInnes
Journal:  AJR Am J Roentgenol       Date:  2014-12       Impact factor: 3.959

6.  Renal Angiomyolipoma: Mid- to Long-Term Results Following Embolization with Onyx.

Authors:  Narayanan Thulasidasan; Srividhiya Sriskandakumar; Shahzad Ilyas; Tarun Sabharwal
Journal:  Cardiovasc Intervent Radiol       Date:  2016-07-28       Impact factor: 2.740

7.  Renal angiomyolipoma: long-term results following selective arterial embolization.

Authors:  Jacob Ramon; Uri Rimon; Alex Garniek; Gil Golan; Paul Bensaid; Noam D Kitrey; Andrei Nadu; Zohar A Dotan
Journal:  Eur Urol       Date:  2008-04-18       Impact factor: 20.096

8.  Percutaneous cryoablation of small kidney tumours under magnetic resonance imaging guidance: medium-term follow-up.

Authors:  Alessandro Caviezel; Sylvain Terraz; Franz Schmidlin; Christoph Becker; Christophe E Iselin
Journal:  Scand J Urol Nephrol       Date:  2008

Review 9.  Meta-analysis of cryoablation versus microwave ablation for small renal masses: is there a difference in outcome?

Authors:  Jason Martin; Sriharsha Athreya
Journal:  Diagn Interv Radiol       Date:  2013 Nov-Dec       Impact factor: 2.630

10.  Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference.

Authors:  Darcy A Krueger; Hope Northrup
Journal:  Pediatr Neurol       Date:  2013-10       Impact factor: 3.372

View more
  7 in total

1.  Can we predict the existence of extrarenal feeders to renal angiomyolipomas?

Authors:  Xixi Zhang; Ryohei Kuwatsuru; Hiroshi Toei; Daiske Yashiro; Shingo Okada; Hitomi Kato
Journal:  Eur Radiol       Date:  2018-12-12       Impact factor: 5.315

2.  Prophylactic selective arterial embolization for renal angiomyolipomas: efficacy and evaluation of predictive factors of significant shrinkage.

Authors:  Letao Lin; Chengen Wang; Renguang Pei; Haitao Guan; Jian Wang; Min Yang; Xiaoqiang Tong; Yinghua Zou
Journal:  Int Urol Nephrol       Date:  2018-08-12       Impact factor: 2.370

3.  Transcatheter arterial embolization for unruptured renal angiomyolipoma using a 1.8-Fr tip microballoon catheter with a mixture of ethanol and Lipiodol.

Authors:  Kosuke Tomita; Tomohiro Matsumoto; Shunsuke Kamei; Shota Yamamoto; Satoshi Suda; Hidenori Zakoji; Terumitsu Hasebe
Journal:  CVIR Endovasc       Date:  2020-01-08

4.  Use of microspheres in embolization for unruptured renal angiomyolipomas.

Authors:  Masashi Shimohira; Keiichi Nagai; Kengo Ohta; Yusuke Sawada; Taku Naiki; Takashi Nagai; Takahiro Yasui; Yuta Shibamoto
Journal:  Open Med (Wars)       Date:  2021-04-20

5.  A new management strategy for renal angiomyolipomas: superselective arterial embolization in combination with radiofrequency ablation.

Authors:  Fengyong Liu; Hongjun Yuan; Xin Li; Jing Tang; Xiaomei Tian; Kan Ji
Journal:  Ann Transl Med       Date:  2019-12

6.  Renal Angiomyolipoma: The Good, the Bad, and the Ugly.

Authors:  Nicolas Vos; Raymond Oyen
Journal:  J Belg Soc Radiol       Date:  2018-04-20       Impact factor: 1.894

Review 7.  Endovascular Interventional Radiology of the Urogenital Tract.

Authors:  Fabio Pozzi Mucelli; Roberta A Pozzi Mucelli; Cristina Marrocchio; Saverio Tollot; Maria A Cova
Journal:  Medicina (Kaunas)       Date:  2021-03-17       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.